Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 356, Issue 2, 1997, Pages 197-202

  Malinowska, Barbara ^a   Godlewski, Grzegorz ^a   Bucher, Bernard ^b   Schlicker, Eberhard ^c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b CNRS   (France)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Cannabinoid receptors; CP 55,940; Noradrenaline release; Pithed rat; Presynaptic receptors; Rat tail artery; SR 141716; WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; BRIMONIDINE; BUPRANOLOL; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; NORADRENALIN; PRESYNAPTIC RECEPTOR; RADIOISOTOPE; RIMONABANT; UNCLASSIFIED DRUG; CYCLOHEXANOL DERIVATIVE; DRUG RECEPTOR; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; VASOCONSTRICTOR AGENT;

ADRENALECTOMY; ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG ANTAGONISM; ELECTROSTIMULATION; ENANTIOMER; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NORADRENALIN RELEASE; PREGANGLIONIC NERVE; PRESSOR RESPONSE; RAT; SPINAL CORD LESION; SYMPATHETIC NERVE; TAIL ARTERY; ACTION POTENTIAL; ANIMAL; BLOOD PRESSURE; DRUG EFFECT; DRUG POTENTIATION; HEART RATE; INNERVATION; METABOLISM; MUSCLE CONTRACTION; VAGOTOMY; VASCULAR SMOOTH MUSCLE;

ACTION POTENTIALS; ADRENALECTOMY; ANIMALS; BLOOD PRESSURE; CYCLOHEXANOLS; ELECTRIC STIMULATION; HEART RATE; MALE; MORPHOLINES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NAPHTHALENES; NOREPINEPHRINE; RATS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; VAGOTOMY; VASOCONSTRICTOR AGENTS;

EID: 0030612584     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005041     Document Type: Article

References (22)

1. 9-tetrahydrocannabinol in the rat. J Pharmacol Exp Ther 196:649-656
2. 2-adrenoceptor modulation of noradrenaline release from the rat tail artery. Naunyn-Schmiedeberg's Arch Pharmacol 342:640-649
3. Bulloch JM, McGrath JC (1988) Blockade of the vasopressor and vas deferens response by α,β-methylene ATP in the pithed rat. Br J Pharmacol 94:103-108
4. Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613
5. Devane WA, Hanuš L, Breuer A, Pertwee R, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949
6. Gifford AN, Ashby CR (1996) Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR141716A. J Pharmacol Exp Ther 277:1431-1436
7. Gillespie JS, Muir TC (1967) A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in pithed rat. Br J Pharmacol 30:78-87
8. Hollister LE (1986) Health aspects of cannabis. Pharmacol Rev 38:1-20
9. Howlett AC (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607-634
10. 1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118:2023-2028
11. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65
12. Pertwee RG, Fernando SR, Griffin G, Abadji V, Makriyannis A (1995) Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Eur J Pharmacol 272:73-78
13. 1 receptors in mouse urinary bladder. Br J Pharmacol 118:2053-2058
14. 1 receptors in guinea-pig small intestine. Br J Pharmacol 118:2199-2205
15. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G (1994) SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244
16. Rinaldi-Carmona M, Barth F, Héaulme M, Alonso R, Shire D, Congy C, Soubrié P, Brelière JC, Le Fur G (1995) Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci 56:1941-1947
17. 2X receptors in the pithed rat. J Autonom Pharmacol 9:357-366
18. Schlicker E, Timm J, Göthert M (1996) Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedeberg's Arch Pharmacol 354:791-795
19. Shen M, Piser TM Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334
20. 9-tetrahydrocannabinol on the rat blood pressure. Eur J Pharmacol 58:351-357
21. 1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278:279-283
22. Varga K, Lake KD, Huangfu D, Guyenet PG, Kunos G (1996) Mechanism of the hypotensive action of anandamide in anaesthetized rats. Hypertension 28:682-686